LLS venture philanthropy invests in five immunotherapy companies
Published
Apr 27 2021 at 4:01 AM GMT
Key
Points
Points
- The Leukemia & Lymphoma Society Therapy Acceleration Program, a venture philanthropy initiative, has announced five investments aimed at accelerating the development of new and improved immunotherapies for the treatment of blood cancers.
Trending
Stats
- Published Apr 27, 2021 4:01 AM GMT